Published in Trends Mol Med on March 02, 2011
The return of metabolism: biochemistry and physiology of the pentose phosphate pathway. Biol Rev Camb Philos Soc (2014) 1.27
Oxidative stress in the pathology and treatment of systemic lupus erythematosus. Nat Rev Rheumatol (2013) 1.27
Transaldolase deficiency: report of 12 new cases and further delineation of the phenotype. J Inherit Metab Dis (2013) 1.09
Mitochondrial dysfunction induces formation of lipid droplets as a generalized response to stress. Oxid Med Cell Longev (2013) 0.98
Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases. Nat Rev Rheumatol (2015) 0.96
mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging. Ann N Y Acad Sci (2015) 0.93
Oncogenic viruses and tumor glucose metabolism: like kids in a candy store. Mol Cancer Ther (2012) 0.89
Transketolase counteracts oxidative stress to drive cancer development. Proc Natl Acad Sci U S A (2016) 0.87
The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan addition. Elife (2016) 0.87
Antioxidant function of isoflavone and 3,3'-diindolylmethane: are they important for cancer prevention and therapy? Antioxid Redox Signal (2013) 0.87
Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin. Metabolomics (2015) 0.85
Transaldolase Deficiency: A New Case Expands the Phenotypic Spectrum. JIMD Rep (2015) 0.84
The proteome of cblC defect: in vivo elucidation of altered cellular pathways in humans. J Inherit Metab Dis (2015) 0.83
Aerobic glycolysis in osteoblasts. Curr Osteoporos Rep (2014) 0.83
Evidence for transaldolase activity in the isolated heart supplied with [U-13C3]glycerol. J Biol Chem (2012) 0.81
Functional analysis of the molecular interactions of TATA box-containing genes and essential genes. PLoS One (2015) 0.78
PharmGKB summary: methylene blue pathway. Pharmacogenet Genomics (2013) 0.78
Liver injury correlates with biomarkers of autoimmunity and disease activity and represents an organ system involvement in patients with systemic lupus erythematosus. Clin Immunol (2015) 0.78
The Amazing Power of Cancer Cells to Recapitulate Extraembryonic Functions: The Cuckoo's Tricks. J Oncol (2011) 0.76
Mitochondrial Dysfunction in the Liver and Antiphospholipid Antibody Production Precede Disease Onset and Respond to Rapamycin in Lupus-Prone Mice. Arthritis Rheumatol (2016) 0.76
Proteomic analysis of mesenchymal stem cells from normal and deep carious dental pulp. PLoS One (2014) 0.76
Pulmonary manifestations in a patient with transaldolase deficiency. JIMD Rep (2013) 0.75
A ROS-Activatable Agent Elicits Homologous Recombination DNA Repair and Synergizes with Pathway Compounds. Chembiochem (2015) 0.75
Altered DNA methylation associated with an abnormal liver phenotype in a cattle model with a high incidence of perinatal pathologies. Sci Rep (2016) 0.75
Polyol accumulation in muscle and liver in a mouse model of type 2 diabetes. J Diabetes Complications (2016) 0.75
The Fas death factor. Science (1995) 13.81
Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology (2005) 10.66
AP-1 as a regulator of cell life and death. Nat Cell Biol (2002) 10.10
Autophagy and metabolism. Science (2010) 8.10
The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science (2010) 6.38
Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med (1997) 5.53
AP-1 subunits: quarrel and harmony among siblings. J Cell Sci (2004) 5.08
Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci U S A (1998) 4.99
Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol (2007) 4.75
Functional interaction between beta-catenin and FOXO in oxidative stress signaling. Science (2005) 4.61
Immunological aspects of demyelinating diseases. Annu Rev Immunol (1992) 4.39
Thioredoxin and thioredoxin reductase. Methods Enzymol (1995) 4.06
Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the risks of hepatic failure. Hepatology (2004) 3.28
Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver. Proc Natl Acad Sci U S A (2003) 3.27
WNT/beta-catenin signaling in liver health and disease. Hepatology (2007) 3.26
Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc Natl Acad Sci U S A (1998) 3.10
Causes and metabolic consequences of Fatty liver. Endocr Rev (2008) 2.84
The pathways of glutamate and glutamine oxidation by tumor cell mitochondria. Role of mitochondrial NAD(P)+-dependent malic enzyme. J Biol Chem (1984) 2.82
Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N Engl J Med (1996) 2.78
Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol (1993) 2.53
Diverse point mutations in the human glucose-6-phosphate dehydrogenase gene cause enzyme deficiency and mild or severe hemolytic anemia. Proc Natl Acad Sci U S A (1988) 2.33
FKBP12-rapamycin-associated protein associates with mitochondria and senses osmotic stress via mitochondrial dysfunction. Proc Natl Acad Sci U S A (2002) 2.14
Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arthritis Rheum (2002) 2.08
Different responses of astrocytes and neurons to nitric oxide: the role of glycolytically generated ATP in astrocyte protection. Proc Natl Acad Sci U S A (2001) 2.03
Carbohydrate metabolism. Annu Rev Biochem (1955) 2.02
Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis. Immunity (1998) 1.88
Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signaling. J Immunol (1999) 1.88
Glucose-6-phosphate dehydrogenase deficiency and malaria. J Mol Med (Berl) (1998) 1.83
Genetically altered mice to evaluate glutathione homeostasis in health and disease. Free Radic Biol Med (2004) 1.76
Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine. J Clin Invest (2009) 1.75
Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma. Br J Cancer (2008) 1.59
HNE interacts directly with JNK isoforms in human hepatic stellate cells. J Clin Invest (1998) 1.59
Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation. J Immunol (2009) 1.52
Fas-mediated apoptosis in primary cultured mouse hepatocytes. Exp Cell Res (1994) 1.41
The molecular basis of glucose-6-phosphate dehydrogenase deficiency. Trends Genet (1992) 1.33
Nonalcoholic steatohepatitis. Semin Liver Dis (1999) 1.32
Glutathione levels and sensitivity to apoptosis are regulated by changes in transaldolase expression. J Biol Chem (1996) 1.28
Screening for hepatocellular carcinoma. J Clin Gastroenterol (2002) 1.28
Transaldolase deficiency: liver cirrhosis associated with a new inborn error in the pentose phosphate pathway. Am J Hum Genet (2001) 1.24
mTOR signaling: a central pathway to pathogenesis in systemic lupus erythematosus? Discov Med (2010) 1.21
CD95 signaling deficient mice with a wild-type hematopoietic system are prone to hepatic neoplasia. Apoptosis (2008) 1.17
Transaldolase: from biochemistry to human disease. Int J Biochem Cell Biol (2009) 1.14
Peroxisomes are oxidative organelles. Antioxid Redox Signal (2010) 1.11
Inhibition of c-Jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M cell cycle arrest. Cancer Res (2005) 1.11
A pathway for the interconversion of hexose and pentose in the parasitic amoeba Entamoeba histolytica. Biochem J (1982) 1.11
Transaldolase deficiency: a new cause of hydrops fetalis and neonatal multi-organ disease. J Pediatr (2006) 1.09
Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis. J Exp Med (1994) 1.05
Molecular ordering in HIV-induced apoptosis. Oxidative stress, activation of caspases, and cell survival are regulated by transaldolase. J Biol Chem (1998) 1.04
Kinetic and chemical mechanisms of the sheep liver 6-phosphogluconate dehydrogenase. Arch Biochem Biophys (1996) 1.03
Transketolase haploinsufficiency reduces adipose tissue and female fertility in mice. Mol Cell Biol (2002) 1.03
Aldose reductase induced by hyperosmotic stress mediates cardiomyocyte apoptosis: differential effects of sorbitol and mannitol. J Biol Chem (2003) 1.03
Application of biochemical systems theory to metabolism in human red blood cells. Signal propagation and accuracy of representation. J Biol Chem (1996) 1.02
Reticulocyte maturation: mitoptosis and exosome release. Biocell (2002) 1.00
Comparison of computer simulations of the F-type and L-type non-oxidative hexose monophosphate shunts with 31P-NMR experimental data from human erythrocytes. Eur J Biochem (1989) 0.99
Transaldolase deficiency in two new patients with a relative mild phenotype. Mol Genet Metab (2009) 0.98
Identification of the binding domain for NADP+ of human glucose-6-phosphate dehydrogenase by sequence analysis of mutants. Proc Natl Acad Sci U S A (1989) 0.98
Novel heterozygous mutations in TALDO1 gene causing transaldolase deficiency and early infantile liver failure. J Pediatr Gastroenterol Nutr (2011) 0.97
CD95-Mediated murine hepatic apoptosis requires an intact glutathione status. Hepatology (1999) 0.97
4-hydroxy-2,3-trans-nonenal induces transcription and expression of aldose reductase. Biochem Biophys Res Commun (1996) 0.95
Transaldolase is essential for maintenance of the mitochondrial transmembrane potential and fertility of spermatozoa. Proc Natl Acad Sci U S A (2006) 0.94
gamma-glutamyltranspeptidase-deficient knockout mice as a model to study the relationship between glutathione status, mitochondrial function, and cellular function. Hepatology (2000) 0.93
Evaluation of a large cohort of men presenting for a screening semen analysis. Fertil Steril (2000) 0.92
ZNF143 mediates basal and tissue-specific expression of human transaldolase. J Biol Chem (2003) 0.91
Expression of potential beta-catenin targets, cyclin D1, c-Jun, c-Myc, E-cadherin, and EGFR in chemically induced hepatocellular neoplasms from B6C3F1 mice. Toxicol Appl Pharmacol (2003) 0.91
Glucose-6-phosphate dehydrogenase deficiency protects against coronary heart disease. J Inherit Metab Dis (2008) 0.91
Transaldolase deficiency influences the pentose phosphate pathway, mitochondrial homoeostasis and apoptosis signal processing. Biochem J (2008) 0.91
Identification of seroreactive proteins in the culture filtrate antigen of Mycobacterium avium ssp. paratuberculosis human isolates to sera from Crohn's disease patients. FEMS Immunol Med Microbiol (2009) 0.90
Deficiency in cytosolic malic enzyme does not increase acetaminophen-induced hepato-toxicity. Basic Clin Pharmacol Toxicol (2008) 0.90
Aspects of carbohydrate metabolism in developing brain. Dev Med Child Neurol (1977) 0.89
The pathogenesis of transaldolase deficiency. IUBMB Life (2007) 0.89
Relationship between posttranslational modification of transaldolase and catalase deficiency in UV-sensitive repair-deficient xeroderma pigmentosum fibroblasts and SV40-transformed human cells. Free Radic Biol Med (2001) 0.88
Human transaldolase and cross-reactive viral epitopes identified by autoantibodies of multiple sclerosis patients. J Immunol (1999) 0.87
CD8+ T cell-mediated HLA-A*0201-restricted cytotoxicity to transaldolase peptide 168-176 in patients with multiple sclerosis. J Immunol (2005) 0.87
Hepatocellular carcinoma. Dis Mon (2004) 0.84
Effect of reversible reactions on isotope label redistribution--analysis of the pentose phosphate pathway. Eur J Biochem (1998) 0.83
Cleavage of transaldolase by granzyme B causes the loss of enzymatic activity with retention of antigenicity for multiple sclerosis patients. J Immunol (2010) 0.82
Changes in pathways of pentose phosphate formation in relation to phosphoribosyl pyrophosphate synthesis in the developing rat kidney. Effects of glucose concentration and electron acceptors. J Dev Physiol (1989) 0.82
Study of transaldolase deficiency in urine samples by capillary LC-MS/MS. J Mass Spectrom (2006) 0.82
Comparative analysis of antibody and cell-mediated autoimmunity to transaldolase and myelin basic protein in patients with multiple sclerosis. J Clin Invest (1997) 0.81
Genetic variation in Transaldolase 1 and risk of squamous cell carcinoma of the head and neck. Cancer Detect Prev (2008) 0.81
Molecular genetics of transketolase in the pathogenesis of the Wernicke-Korsakoff syndrome. Metab Brain Dis (1995) 0.80
Deletion of Ser-171 causes inactivation, proteasome-mediated degradation and complete deficiency of human transaldolase. Biochem J (2004) 0.80
Regulation and rate of the hexose monophosphate shunt in Rana ridibunda erythrocytes. Comp Biochem Physiol B (1990) 0.78
Glucose-6-phosphate dehydrogenase is enriched in oligodendrocytes of the rat spinal cord. Enzyme histochemical and immunocytochemical studies. Histochemistry (1994) 0.77
8-azaguanine and flavinogenesis in Eremothecium ashbyii. Biochim Biophys Acta (1975) 0.76
Spatial distribution of fibrosis governs fibrillation wave dynamics in the posterior left atrium during heart failure. Circ Res (2007) 3.51
Positive end-expiratory pressure after a recruitment maneuver prevents both alveolar collapse and recruitment/derecruitment. Am J Respir Crit Care Med (2003) 2.06
Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine. J Clin Invest (2009) 1.75
Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation. J Immunol (2009) 1.52
Instillation of mitomycin C after transurethral resection of bladder cancer impairs wound healing: an animal model. Anticancer Res (2011) 1.50
Higher than expected association of clinical prostate and bladder cancers. J Urol (2008) 1.49
N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum (2012) 1.38
Expression of prostate-specific membrane antigen in normal and malignant human tissues. World J Surg (2006) 1.23
The kinase Mirk/Dyrk1B mediates cell survival in pancreatic ductal adenocarcinoma. Cancer Res (2006) 1.17
Regulation of CD4 expression via recycling by HRES-1/RAB4 controls susceptibility to HIV infection. J Biol Chem (2006) 1.16
Atrial myxomas: pathologic types, tumor location, and presenting symptoms. J Card Surg (2006) 1.16
Metalloproteinase inhibition reduces lung injury and improves survival after cecal ligation and puncture in rats. J Surg Res (2003) 1.06
Central role of nitric oxide in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res Ther (2010) 1.05
Higher than expected association of clinical prostate and bladder cancers. J Urol (2005) 0.97
Murine lupus susceptibility locus Sle1c2 mediates CD4+ T cell activation and maps to estrogen-related receptor γ. J Immunol (2012) 0.96
Endogenous retroviral pathogenesis in lupus. Curr Opin Rheumatol (2010) 0.95
T-cell and B-cell signaling biomarkers and treatment targets in lupus. Curr Opin Rheumatol (2009) 0.94
Molecular mimicry and immunomodulation by the HRES-1 endogenous retrovirus in SLE. Autoimmunity (2008) 0.93
Assessment of mitochondrial dysfunction in lymphocytes of patients with systemic lupus erythematosus. Methods Mol Biol (2012) 0.92
An improved liquid chromatography-tandem mass spectrometry method for the quantification of 4-aminobiphenyl DNA adducts in urinary bladder cells and tissues. J Chromatogr A (2009) 0.90
Increased mitochondrial electron transport chain activity at complex I is regulated by N-acetylcysteine in lymphocytes of patients with systemic lupus erythematosus. Antioxid Redox Signal (2014) 0.90
Interplay of infections, autoimmunity, and immunosuppression in systemic lupus erythematosus. Int Rev Immunol (2014) 0.87
Chemically modified tetracycline (COL-3) improves survival if given 12 but not 24 hours after cecal ligation and puncture. Shock (2006) 0.82
Risk of post-operative intravesical mitomycin C instillation following transurethral bladder tumor resection. Can J Urol (2006) 0.81
High prevalence of bilateral varicoceles confirmed with ultrasonography. Int Urol Nephrol (2003) 0.76
Anatomy of the upper lateral cartilage along the lateral pyriform aperture. Plast Reconstr Surg (2015) 0.75
Enteric cyst with epicardial attachment to the left ventricle. Cardiovasc Pathol (2006) 0.75
Novel association of elastofibroma with aortic stenosis: report of a case report interfering with a thoracotomy procedure and a reassessment of typical patient demographics and tumor location. J Thorac Oncol (2015) 0.75
Chemically modified tetracycline improves contractility in porcine coronary ischemia/reperfusion injury. J Card Surg (2006) 0.75
Large teratoma at aortic bifurcation: an unusual metastasis of testicular cancer. Can J Urol (2012) 0.75